H
Hamao Umezawa
Researcher at National Institutes of Health
Publications - 943
Citations - 25547
Hamao Umezawa is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Streptomyces & Kanamycin. The author has an hindex of 74, co-authored 943 publications receiving 25106 citations.
Papers
More filters
Journal ArticleDOI
Bestatin, an inhibitor of aminopeptidase b, produced by actinomycetes
TL;DR: In this article, a new compound bestatin was discovered and the discovery and isolation of which are reported in the literature, which is an exopeptidase which can be obtained from rat liver, and it hydrolyses an N-terminal peptide bond containing Nterminal arginine or lysine.
Journal ArticleDOI
Pepstatin, a new pepsin inhibitor produced by agtinomygetes
Journal ArticleDOI
Leupeptins, new protease inhibitors from Actinomycetes.
Takaaki Aoyagi,Tomio Takeuchi,Akinori Matsuzaki,Kenji Kawamura,Shinichi Kondo,Masa Hamada,Kenji Maeda,Hamao Umezawa +7 more
Journal ArticleDOI
Studies on a new epidermal growth factor-receptor kinase inhibitor, erbstatin, produced by MH435-hF3.
Hamao Umezawa,Masaya Imoto,Tsutomu Sawa,Kunio Isshiki,Naoko Matsuda,Takeshi Uchida,Hironobu Iinuma,Masa Hamada,Tomio Takeuchi +8 more